Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44]

The summary for the Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44] grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44]: Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), at the National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) propose to develop new technologies and/or improve existing technologies for the detection and evaluation of chemical and biological carcinogens in clinical and/or environmental specimens. These technologies should be amenable to automation and high sample throughput. The ultimate goal of this initiative is to develop innovative carcinogen detection technologies to the stage of commercially viable assays. Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications. Other related FOAs that also use the SBIR mechanism are PA-09-188 and PA-09-189. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received.
Federal Grant Title: Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44]
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-09-187
Type of Funding: Grant
CFDA Numbers: 93.396
CFDA Descriptions: Cancer Biology Research
Current Application Deadline: May 07, 2012
Original Application Deadline: May 07, 2012
Posted Date: May 19, 2009
Creation Date: May 19, 2009
Archive Date: Jun 07, 2012
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allow...
Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Tr...
Advancing Cancer Control Equity Research through Transformative Solutions Coordination Cen...
Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial O...
Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional...
Mouse Models of Human Cancers Consortium
Integrative Cancer Biology Programs
Memory T Lymphocytes in Cancer Immunology (R21)
More Grants from the National Institutes of Health
Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com